What the safety studies found
Across the controlled literature — single-dose PK work, an escalation study reaching ~62 mg/kg (fifteen times the event dose), and 26 weeks of daily 4 mg/kg — CBD-dominant products were well tolerated. The recurring findings: occasional soft stool, mild drowsiness at higher doses, and elevated alkaline phosphatase (ALP) on bloodwork in a subset of dogs.
The three caveats that matter
- The ALP signal. Elevated liver enzymes without illness, reversible — but it means long-term users should get periodic bloodwork, and dogs with liver disease need vet sign-off first.
- Drug interactions. CBD competes for CYP450 liver enzymes. Seizure medications, some cardiac drugs, and others clear through the same pathway. On any prescription: vet before CBD, not after.
- THC, the actual danger. CBD's safety record is NOT marijuana's. THC causes real toxicosis in dogs — ataxia, urinary incontinence, terror. The only defense is the COA: THC non-detect or <0.3%, batch-matched to your bottle.
Side effects, ranked by how often they're reported
- Drowsiness — dose-dependent; at anxiety doses it should read "settled," not sedated.
- Soft stool / GI upset — usually the first week; often resolves at a lower tier.
- Dry mouth / extra thirst — mild and common.
- ALP elevation — lab-only finding; the reason for monitoring.
- Vomiting — uncommon; often the carrier oil, not the CBD; switching products frequently fixes it.